Listed

Enveric Biosciences, Inc.: Form 10-Q for the period ended Mar 31, 2016

Filed with the SEC on May 16, 2016 and accepted by EDGAR at May 16, 2016, 17:14 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-01-01 to 2016-03-31$7.0mus-gaap:SalesRevenueNet
Cost of revenue3 months2016-01-01 to 2016-03-31$3.9mus-gaap:CostOfRevenue
Gross profit3 months2016-01-01 to 2016-03-31$3.1mus-gaap:GrossProfit
Operating income3 months2016-01-01 to 2016-03-31−$981.3kus-gaap:OperatingIncomeLoss
Interest expense3 months2016-01-01 to 2016-03-31$113.7kus-gaap:InterestExpense
Income tax3 months2016-01-01 to 2016-03-31$2.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-01-01 to 2016-03-31−$1.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-01-01 to 2016-03-31−$0.10us-gaap:EarningsPerShareDiluted
Basic EPS3 months2016-01-01 to 2016-03-31−$0.10us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2016-01-01 to 2016-03-3111,874,361 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2016-01-01 to 2016-03-31−$1.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2016-03-31$505.2kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-03-31$5.8mus-gaap:AssetsCurrent
Total assetsAt period end2016-03-31$12.6mus-gaap:Assets
Current liabilitiesAt period end2016-03-31$7.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-03-31$13.4mus-gaap:Liabilities
Long-term debtAt period end2016-03-31$5.5mus-gaap:LongTermDebt
Shareholders' equityAt period end2016-03-31−$800.1kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001079974-16-001197. Last ingested by Listed: Nov 14, 2026, 20:02 ET. Listed shows no prices and gives no investment advice.